EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessment of tertiary lymphoid structures via 18F-FDG PET/CT scan in patients with pancreatic adenocarcinoma

Yu Yan, Xuan Zou, Xuan Lin, Xu Wang, Yusheng Chen, Mingjian Ma, Xu Wang, Mengxing Pan, Xianjun Yu, Chen Liu, He Cheng

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-025-04205-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Yu Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Pancreatic Neoplasms, Fluorodeoxyglucose F18, Tertiary Lymphoid Structures. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Young Scientist Project of National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic adenocarcinoma (PAAD) is one of the most malignancies with a poor prognosis. The immune phenotype of pancreatic cancer is remarkably complex, presenting a significant challenge to the efficacy of immunotherapy. Tertiary lymphoid structures (TLSs) are active zones composed of various immune cells, which reflect immune responses against cancer. TLSs have emerged as critical biomarkers for predicting immunotherapy outcomes, potentially reflecting alterations in the metabolic characteristics of the host. Accumulating evidence indicates that 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) may shed light on cancer immunology. The tumor environment is known to be associated with the metabolic activity and antitumor immunity of immune cells. A total of 266 patients with PAAD who underwent 18F-FDG PET/CT followed by pancreatectomy were enrolled in this study, and the presence of TLSs was identified in 66 patients by HE staining, and fluorescent multiplex immunohistochemistry (mIHC) was employed to analyze the cellular composition of TLSs. Elevated maximum standard uptake values (SUVmax) showed significant correlation with TLS presence in PAAD patients. However, SUVmax value showed no correlation with overall survival in PAAD patients. Immunohistochemistry (IHC) staining demonstrated a statistically significant correlation between higher SUVmax levels and increased CD4 + and CD8 + tumor-infiltrating lymphocytes. In PAAD patients with TLS, CD4⁺ T-cell infiltration levels showed a positive correlation with SUVmax. In our study, a TLS signature containing 12-chemokine was proposed to determine high TLS score and low TLS score group. The high TLS score group exhibited increased infiltration of naïve/memory/activated B cells, central memory/activated CD4⁺/CD8⁺ T cells, Tregs, Th1/Th2/Th17 subsets, and neutrophils. Furthermore, GLUT3 and GLUT10 expression consistently correlated with TLS scores in both TCGA and CPTAC cohorts. GLUT3 and GLUT10 were found to be upregulated in the high TLS score group. A more inflamed immune infiltrative landscape was characterized in the high TLS score group with a high proportion of multiple immune cells. Increased FDG uptake is often induced by overexpression of glucose transporters (GLUT) and glucometabolic genes. Overexpression of GLUT3 and GLUT10 was found to be positively correlated with higher infiltration levels as well as immune activation of CD4+ and CD8+ T cells. To conclude, our study showed an association between SUVmax on 18F-FDG PET/CT and TLS presence in PAAD. FDG uptake may reflect local immune responses and glucose metabolism associated with TLS presence in PAAD. 18F-FDG PET/CT may serve as a non-invasive and aided tool for assessing the presence of TLS in tumor immune environment and predicting antitumor immunity in PAAD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyPancreatic NeoplasmsFluorodeoxyglucose F18Tertiary Lymphoid StructuresAdenocarcinomaHumansMaleFemaleMiddle AgedAgedPrognosisAdultAged, 80 and overLymphocytes, Tumor-Infiltrating

Stichwörter der Autor:innen

18F-fluorodeoxyglucose positron emission tomography /computed tomography (18F-F…Pancreatic adenocarcinoma (PAAD)Tertiary lymphoid structuresTumor microenvironment

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, No.270 Dong An Road, Xu-Hui District, Shanghai, 200032, China.
  • Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China.
  • Pancreatic Cancer Institute, Fudan University, No.270 Dong An Road, Xu-Hui District, Shanghai, 200032, China.
  • Shanghai Key Laboratory of Radiation Oncology, Fudan University Shanghai Cancer Center, Cancer Research Institute, Fudan University, No.270 Dong An Road, Xu-Hui District, Shanghai, 200032, China.
  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. yuxianjun@fudanpci.org.

Förderung

  • the National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Young Scientist Project of National Key Research and Development Program of China
  • The Scientific Innovation Project of Shanghai Education Committee
  • Shanghai Municipal Science and Technology Major Project
  • Clinical and Scientific Innovation Project of Shanghai Hospital Development Center
  • Clinical Research Plan of Shanghai Hospital Development Center
  • National Key Research and Development Program of China

Zitieren

APA

Yan, Y., Zou, X., Lin, X., Wang, X., Chen, Y., Ma, M., Wang, X., Pan, M., Yu, X., Liu, C., & Cheng, H. (2025). Assessment of tertiary lymphoid structures via 18F-FDG PET/CT scan in patients with pancreatic adenocarcinoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04205-x

Vancouver

Yan Y, Zou X, Lin X, Wang X, Chen Y, Ma M, et al. Assessment of tertiary lymphoid structures via 18F-FDG PET/CT scan in patients with pancreatic adenocarcinoma. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04205-x

BibTeX
@article{Yan2025,
  author = {Yan, Yu and Zou, Xuan and Lin, Xuan and Wang, Xu and Chen, Yusheng and Ma, Mingjian and Wang, Xu and Pan, Mengxing and Yu, Xianjun and Liu, Chen and Cheng, He},
  title = {Assessment of tertiary lymphoid structures via 18F-FDG PET/CT scan in patients with pancreatic adenocarcinoma},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-025-04205-x}
}
Kostenlos starten →